Advanced Renal Cell Carcinoma Completed Phase 2 Trials for ABT-869 (DB06080)

Also known as: Advanced Renal cell carcinoma

IndicationStatusPhase
DBCOND0032596 (Advanced Renal Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00486538Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With SunitinibTreatment